PyInvesting

Market research

GBE.F Genus plc

F EUR Healthcare

Latest close

25.60 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
2B
P/E ratio
5.61
Analyst target
Not available
Dividend yield
1.2%
Beta
0.86

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Genus plc is currently in a long term uptrend where the price is trading 11.0% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.6.

Genus plc's total revenue sank by 0.0% to $135M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $12M since the same quarter in the previous year.

Finally, its free cash flow grew by 120.0% to $14M since the same quarter in the previous year.

Based on the above factors, Genus plc gets an overall score of 3/5.